首页> 外文期刊>IEEE Transactions on Biomedical Engineering >Hemodynamic management of congestive heart failure by means of a multiple mode rule-based control system using fuzzy logic
【24h】

Hemodynamic management of congestive heart failure by means of a multiple mode rule-based control system using fuzzy logic

机译:基于多模式基于规则的模糊逻辑控制系统对充血性心力衰竭的血流动力学管理

获取原文
获取原文并翻译 | 示例
       

摘要

A rule-based system was designed to control the mean arterial pressure (MAP) and the cardiac output (GO) of a patient with congestive heart failure (CHF), using two vasoactive drugs; sodium nitroprusside (SNP) and dopamine (DPM). The controller has three different modes, that engage according to the hemodynamic state. The critical conditions control mode (CCC) determines the initial infusion rates, and continues active if the MAP or the CO fall outside of the defined critically thresholds: an upper and a lower boundary for the MAP and a lower boundary for the CO. Inside the boundaries the control is performed by noncritical conditions control modes (NCC's), which are fuzzy logic controllers. If the CO is within normal range and the MAP is close to the goal range, then the MAP is driven using only SNP, in a single-input-single-output mode (NCC-SISO). Otherwise the NCC multiple input-multiple-output is active (NCC-MIMO). The goal values for the controlled variables are defined as a band of 5 mmHg for the MAP and 5 mL/kg/min for the CO, but there is little concern for this application if the CO is too high (i.e., in practical terms the CO only needs to achieve a necessary minimum rate). The NCC-MIMO includes a gain adaptation algorithm to cope with the wide variety in sensitivities to SNP. Supervisory capabilities to ensure adequate drug delivery complete the controller scheme. After extensive testing and tuning on a CHF-hemodynamics nonlinear model, the control system was applied in dog experiments, which led to further enhancements. The results show an adequate control, presenting a fast response to setpoint changes with an acceptable overshoot.
机译:设计了一种基于规则的系统,使用两种血管活性药物控制充血性心力衰竭(CHF)患者的平均动脉压(MAP)和心输出量(GO)。硝普钠(SNP)和多巴胺(DPM)。控制器具有三种不同的模式,可以根据血液动力学状态进行接合。临界条件控制模式(CCC)确定初始输液速度,如果MAP或CO超出定义的临界阈值,则继续激活:MAP的上下边界和CO的下边界。通过非临界条件控制模式(NCC)进行控制,该模式是模糊逻辑控制器。如果CO在正常范围内,而MAP接近目标范围,则仅在单输入单输出模式(NCC-SISO)下使用SNP驱动MAP。否则,NCC多输入多输出处于活动状态(NCC-MIMO)。控制变量的目标值被定义为MAP的5 mmHg谱带和CO的5 mL / kg / min谱带,但是如果CO太高(即,实际上是CO只需达到必要的最低费率即可。 NCC-MIMO包括增益自适应算法,以应对对SNP的多种敏感度。确保足够药物输送的监督能力完善了控制器方案。经过对CHF血流动力学非线性模型进行广泛的测试和调整后,该控制系统被应用于狗实验中,从而带来了进一步的增强。结果显示出适当的控制,可以快速响应设定值变化并具有可接受的超调量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号